Reactive oxygen species modulation of Na/K-ATPase regulates fibrosis and renal proximal tubular sodium handling

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Liu, Jiang ^a   Kennedy, David J ^b   Yan, Yanling ^a,c   Shapiro, Joseph I ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c YANSHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866151491     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/381320     Document Type: Review

References (234)

1. Calhoun D. A., Jones D., Textor S., Goff D. C., Murphy T. P., Toto R. D., White A., Cushman W. C., White W., Sica D., Ferdinand K., Giles T. D., Falkner B., Carey R. M., Resistant hypertension: siagnosis, evaluation, and treatment a scientific statement from the american heart association professional education committee of the council for high blood pressure research. Hypertension 2008 51 6 1403 1419 2-s2.0-49249106417 10.1161/HYPERTENSIONAHA.108.189141
2. He F. J., MacGregor G. A., Effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews 2004 3 CD004937 2-s2.0-16544378384
3. Guyton A. C., Blood pressure controlspecial role of the kidneys and body fluids. Science 1991 252 5014 1813 1816 2-s2.0-0025817650 (Pubitemid 21917099)
4. Staessen J. A., Wang J., Bianchi G., Birkenhäger W. H., Essential hypertension. Lancet 2003 361 9369 1629 1641 2-s2.0-0037906525 10.1016/S0140-6736(03)13302-8 (Pubitemid 36579003)
5. Weinberger M. H., Miller J. Z., Luft F. C., Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986 8 6 II127 II134 2-s2.0-0011879431 (Pubitemid 16035851)
6. Sacks F. M., fsacks@hsph.harvard.edu Svetkey L. P., Vollmer W. M., Appel L. J., Bray G. A., Harsha D., Obarzanek E., Conlin P. R., Miller III E. R., Simons-Morton D. G., Karanja N., Lin P. -H., Aickin M., Most-Windhauser M. M., Moore T. J., Proschan M. A., Cutler J. A., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. New England Journal of Medicine 2001 344 1 3 10 10.1056/NEJM200101043440101 (Pubitemid 32064838)
7. Dahl L. K., Heine M., Thompson K., Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circulation Research 1974 40 4 94 101 2-s2.0-0015951071
8. Bianchi G., The hypertensive role of the kidney in spontaneously hypertensive rats. Clinical Science and Molecular Medicine 1973 23 45, Supplement 1 S135 S139 2-s2.0-0015866028
9. Heller J., Schubert G., Havlickova J., Thurau K., The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflugers Archiv European Journal of Physiology 1993 425 3-4 208 212 2-s2.0-0027507479 10.1007/BF00374168 (Pubitemid 23338836)
10. Morgan D. A., DiBona G. F., Mark A. L., Effects of interstrain renal transplantation of NaCl-induced hypertension in Dahl rats. Hypertension 1990 15 4 436 442 2-s2.0-0025248725 (Pubitemid 20137601)
11. Curtis J. J., Luke R. G., Dustan H. P., Remission of essential hypertension after renal transplantation. New England Journal of Medicine 1983 309 17 1009 1015 2-s2.0-0020523757 (Pubitemid 13014770)
12. Bagrov A. Y., Shapiro J. I., Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nature Clinical Practice Nephrology 2008 4 7 378 392 2-s2.0-46249110505 10.1038/ncpneph0848 (Pubitemid 351913708)
13. Buckalew V. M., Endogenous digitalis-like factors. An historical overview. Frontiers in Bioscience 2005 10 1 2325 2334 2-s2.0-21344431898 (Pubitemid 40905303)
14. Fedorova O. V., Shapiro J. I., Bagrov A. Y., Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochimica et Biophysica Acta 2010 1802 12 1230 1236 2-s2.0-78049306500 10.1016/j.bbadis.2010.03.011
15. Liu J., Xie Z. J., The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochimica et Biophysica Acta 2010 1802 12 1237 1245 2-s2.0-78049262472 10.1016/j.bbadis.2010.01.013
16. Schoner W., Scheiner-Bobis G., Role of endogenous cardiotonic steroids in sodium homeostasis. Nephrology Dialysis Transplantation 2008 23 9 2723 2729 2-s2.0-58149225539 10.1093/ndt/gfn325
17. Meneton P., Jeunemaitre X., De Wardener H. E., Macgregor G. A., Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiological Reviews 2005 85 2 679 715 2-s2.0-15544364940 10.1152/physrev.00056.2003 (Pubitemid 40404639)
18. Schoner W., Scheiner-Bobis G., Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. American Journal of Physiology, Cell Physiology 2007 293 2 C509 C536 2-s2.0-34547733409 10.1152/ajpcell.00098.2007 (Pubitemid 47235171)
19. Hamlyn J. M., Blaustein M. P., Bova S., DuCharme D. W., Harris D. W., Mandel F., Mathews W. R., Ludens J. H., Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences of the United States of America 1991 88 14 6259 6263 2-s2.0-0025821399 (Pubitemid 21914926)
20. Laredo J., Shah J. R., Lu Z. R., Hamilton B. P., Hamlyn J. M., Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997 29 1 401 407 2-s2.0-0031017359 (Pubitemid 27074075)
21. Bagrov A. Y., Shapiro J. I., Fedorova O. V., Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacological Reviews 2009 61 1 9 38 2-s2.0-63849168850 10.1124/pr.108.000711
22. +-ATPase. Biochimica et Biophysica Acta 1989 988 2 185 220 2-s2.0-0024564828 (Pubitemid 19129678)
23. Kaplan J. H., Biochemistry of Na,K-ATPase. Annual Review of Biochemistry 2002 71 511 535 10.1146/annurev.biochem.71.102201.141218 (Pubitemid 34800229)
24. Blanco G., Mercer R. W., Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. American Journal of Physiology 1998 275 5 F633 F650 2-s2.0-0031758268
25. Sanchez G., Nguyen A. N. T., Timmerberg B., Tash J. S., Blanco G., The Na,K-ATPase α 4 isoform from humans has distinct enzymatic properties and is important for sperm motility. Molecular Human Reproduction 2006 12 9 565 576 2-s2.0-33750382787 10.1093/molehr/gal062 (Pubitemid 44642442)
26. Barwe S. P., Anilkumar G., Moon S. Y., Zheng Y., Whitelegge J. P., Rajasekaran S. A., Rajasekaran A. K., Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Molecular Biology of the Cell 2005 16 3 1082 1094 2-s2.0-14844315982 10.1091/mbc.E04-05-0427 (Pubitemid 40349547)
27. Beggah A. T., Geering K., α and β subunits of Na,K-ATPase interact with BiP and calnexin. Annals of the New York Academy of Sciences 1997 834 537 539 2-s2.0-0031454582 10.1111/j.1749-6632.1997.tb52311.x (Pubitemid 28009118)
28. Feschenko M. S., Wetzel R. K., Sweadner K. J., Phosphorylation of Na,K-ATPase by protein kinases. Sites, susceptibility, and consequences. Annals of the New York Academy of Sciences 1997 834 479 488 2-s2.0-0031442615 10.1111/j.1749-6632.1997.tb52306.x (Pubitemid 28009113)
29. +-ATPase. Journal of Biological Chemistry 1995 270 50 29971 29975 2-s2.0-0029591842 10.1074/jbc.270.50.29971 (Pubitemid 26001672)
30. Lee K., Jung J., Kim M., Guidotti G., Interaction of the α subunit of Na,K-ATPase with, cofilin. Biochemical Journal 2001 353 2 377 385 2-s2.0-0035863252 10.1042/0264-6021:3530377 (Pubitemid 32096948)
31. +-ATPase forms a functional signaling complex. Molecular Biology of the Cell 2006 17 1 317 326 2-s2.0-30044451651 10.1091/mbc.E05-08-0735 (Pubitemid 43049484)
32. Xie Z., Cai T., Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 2003 3 3 157 168 2-s2.0-2342487353
33. +-ATPase α subunit and regulates its trafficking. Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6556 6561 2-s2.0-0034612370 (Pubitemid 30412752)
34. Zhang Z., Devarajan P., Dorfman A. L., Morrow J. S., Structure of the ankyrin-binding domain of α -Na,K-ATPase. Journal of Biological Chemistry 1998 273 30 18681 18684 2-s2.0-0032563192 10.1074/jbc.273.30.18681 (Pubitemid 28366246)
35. Song H., Lee M. Y., Kinsey S. P., Weber D. J., Blaustein M. P., An N-terminal sequence targets and tethers Na+ pump α 2 subunits to specialized plasma membrane microdomains. Journal of Biological Chemistry 2006 281 18 12929 12940 2-s2.0-33744948791 10.1074/jbc.M507450200 (Pubitemid 43855386)
36. Zhang S., Malmersjö S., Li J., Ando H., Aizman O., Uhlén P., Mikoshiba K., Aperia A., Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer. Journal of Biological Chemistry 2006 281 31 21954 21962 2-s2.0-33746839661 10.1074/jbc.M601578200 (Pubitemid 44181899)
37. Kaplan J. H., A moving new role for the sodium pump in epithelial cells and carcinomas. Science's STKE 2005 2005 289 pe31 2-s2.0-33644876479
38. Kaunitz J. D., Membrane transport proteins: not just for transport anymore. American Journal of Physiology 2006 290 5 F995 F996 2-s2.0-33646570540 10.1152/ajprenal.00515.2005 (Pubitemid 43724897)
39. Li Z., Xie Z., The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Archiv European Journal of Physiology 2009 457 3 635 644 2-s2.0-62149104775 10.1007/s00424-008-0470-0
40. Aizman O., Uhlén P., Lal M., Brismar H., Aperia A., Ouabain, a steroid hormone that signals with slow calcium oscillations. Proceedings of the National Academy of Sciences of the United States of America 2001 98 23 13420 13424 2-s2.0-0035818504 10.1073/pnas.221315298 (Pubitemid 33051378)
41. Aydemir-Koksoy A., Abramowitz J., Allen J. C., Ouabain-induced signaling and vascular smooth muscle cell proliferation. Journal of Biological Chemistry 2001 276 49 46605 46611 2-s2.0-0035824551 10.1074/jbc.M106178200
42. Li J., Zelenin S., Aperia A., Aizman O., Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF- κ B. Journal of the American Society of Nephrology 2006 17 7 1848 1857 2-s2.0-33745818598 10.1681/ASN.2005080894 (Pubitemid 44036169)
43. Saunders R., Scheiner-Bobis G., Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. European Journal of Biochemistry 2004 271 5 1054 1062 2-s2.0-1542374561 10.1111/j.1432-1033.2004.04012.x (Pubitemid 38299659)
44. Kotova O., Al-Khalili L., Talia S., Hooke C., Fedorova O. V., Bagrov A. Y., Chibalin A. V., Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. Journal of Biological Chemistry 2006 281 29 20085 20094 2-s2.0-33745991973 10.1074/jbc.M601577200 (Pubitemid 44065783)
45. Khundmiri S. J., Metzler M. A., Ameen M., Amin V., Rane M. J., Delamere N. A., Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells. American Journal of Physiology, Cell Physiology 2006 291 6 C1247 C1257 2-s2.0-33845318534 10.1152/ajpcell.00593.2005 (Pubitemid 44878596)
46. Trevisi L., Visentin B., Cusinato F., Pighin I., Luciani S., Antiapoptotic effect of ouabain on human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 2004 321 3 716 721 2-s2.0-4344688187 10.1016/j.bbrc.2004.07.027 (Pubitemid 39118396)
47. Ferrari P., Ferrandi M., Valentini G., Manunta P., Bianchi G., Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Medical Hypotheses 2007 68 6 1307 1314 2-s2.0-33947689804 10.1016/j.mehy.2006.07.058 (Pubitemid 46498426)
48. Golden W. C., Martin L. J., Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo. Neuroscience 2006 137 1 133 144 2-s2.0-29744469808 10.1016/j.neuroscience.2005.10.004 (Pubitemid 43031481)
49. Jiang X., Ren Y. P., Lü Z. R., Ouabain induces cardiac remodeling in rats independent of blood pressure. Acta Pharmacologica Sinica 2007 28 3 344 352 2-s2.0-33847229134 10.1111/j.1745-7254.2007.00496.x
50. Li M., Wang Q., Guan L., Effects of ouabain on proliferation, intracellular free calcium and c-myc mRNA expression in vascular smooth muscle cells. Journal of Comparative Physiology B 2007 177 5 589 595 2-s2.0-34249876339 10.1007/s00360-007-0157-4 (Pubitemid 46872942)
51. Skoumal R., Szokodi I., Aro J., Földes G., Göoz M., Seres L., Sármán B., Lakó-Futó Z., Papp L., Vuolteenaho O., Leppäluoto J., deChâtel R., Ruskoaho H., Tóth M., Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo. Life Sciences 2007 80 14 1303 1310 2-s2.0-33847262462 10.1016/j.lfs.2006.12.026
52. +-ATPase α subunit in the synaptic plasma membrane of rat brain. Neuroscience Letters 2007 413 1 42 45 2-s2.0-33846443692 10.1016/j.neulet.2006.11.061 (Pubitemid 46149185)
53. + ATPase as a signaling molecule during bovine sperm capacitation. Biology of Reproduction 2006 75 3 308 317 2-s2.0-33747587610 10.1095/biolreprod.105.047852 (Pubitemid 44268064)
54. Larre I., Ponce A., Fiorentino R., Shoshani L., Contreras R. G., Cereijido M., Contacts and cooperation between cells depend on the hormone ouabain. Proceedings of the National Academy of Sciences of the United States of America 2006 103 29 10911 10916 2-s2.0-33746631266 10.1073/pnas.0604496103 (Pubitemid 44148394)
55. Nguyen A. N. T., Wallace D. P., Blanco G., Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation. Journal of the American Society of Nephrology 2007 18 1 46 57 2-s2.0-33845977762 10.1681/ASN.2006010086 (Pubitemid 46053421)
56. Dmitrieva R. L., Doris P. A., Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells. Journal of Biological Chemistry 2003 278 30 28160 28166 2-s2.0-0041344556 10.1074/jbc.M303768200 (Pubitemid 36900015)
57. Larre I., Lazaro A., Contreras R. G., Balda M. S., Matter K., Flores-Maldonado C., Ponce A., Flores-Benitez D., Rincon-Heredia R., Padilla-Benavides T., Castillo A., Shoshani L., Cereijido M., Ouabain modulates epithelial cell tight junction. Proceedings of the National Academy of Sciences of the United States of America 2010 107 25 11387 11392 2-s2.0-77954948413 10.1073/pnas.1000500107
58. Rajasekaran A. K., Rajasekaran S. A., Role of Na-K-ATPase in the assembly of tight junctions. American Journal of Physiology 2003 285 3 F388 F396 2-s2.0-0042967427 (Pubitemid 37010849)
59. Blaustein M. P., Zhang J., Chen L., Song H., Raina H., Kinsey S. P., Izuka M., Iwamoto T., Kotlikoff M. I., Lingrel J. B., Philipson K. D., Wier W. G., Hamlyn J. M., The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009 53 2 291 298 2-s2.0-59849096582 10.1161/HYPERTENSIONAHA.108.119974
60. Bagrov A. Y., Fedorova O. V., Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Frontiers in Bioscience 2005 10 1 2250 2256 2-s2.0-21344446365 (Pubitemid 40905296)
61. Bertorello A. M., Sznajder J. I., The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks. American Journal of Respiratory Cell and Molecular Biology 2005 33 5 432 437 2-s2.0-27644446481 10.1165/rcmb.2005-0297TR (Pubitemid 41572685)
62. Liu J., Shapiro J. I., Regulation of sodium pump endocytosis by cardiotonic steroids: molecular mechanisms and physiological implications. Pathophysiology 2007 14 3-4 171 181 2-s2.0-36448975777 10.1016/j.pathophys.2007. 09.008 (Pubitemid 350166889)
63. +-ATPase as a signal transducer. European Journal of Biochemistry 2002 269 10 2434 2439 2-s2.0-0036098774 10.1046/j.1432-1033.2002.02910.x (Pubitemid 34539270)
64. Aperia A., New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. Journal of Internal Medicine 2007 261 1 44 52 2-s2.0-33846011388 10.1111/j.1365-2796.2006.01745.x (Pubitemid 46046471)
65. Kelly R. A., Smith T. W., The search for the endogenous digitalis: an alternative hypothesis. American Journal of Physiology 1989 256 5 C937 C950 2-s2.0-0024563223
66. Foulkes R., Ferrario R. G., Salvati P., Bianchi G., Differences in ouabain-induced natriuresis between isolated kidneys of Milan hypertensive and normotensive rats. Clinical Science 1992 82 2 185 190 2-s2.0-0026605184
67. Yates N. A., McDougall J. G., Effect of volume expansion on the natriuretic response to ouabain infusion. Renal Physiology and Biochemistry 1995 18 6 311 320 2-s2.0-0029617668 (Pubitemid 26069552)
68. Dostanic-Larson I., van Huysse J. W., Lorenz J. N., Lingrel J. B., The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America 2005 102 44 15845 15850 2-s2.0-27644466627 10.1073/pnas.0507358102 (Pubitemid 41552830)
69. Loreaux E. L., Kaul B., Lorenz J. N., Lingrel J. B., Ouabain-sensitive α 1 Na,K-ATPase enhances natriuretic response to saline load. Journal of the American Society of Nephrology 2008 19 10 1947 1954 2-s2.0-54049128495 10.1681/ASN.2008020174
70. Nesher M., Dvela M., Igbokwe V. U., Rosen H., Lichtstein D., Physiological roles of endogenous ouabain in normal rats. American Journal of Physiology, Heart and Circulatory Physiology 2009 297 6 H2026 H2034 2-s2.0-72249113150 10.1152/ajpheart.00734.2009
71. Fedorova O. V., Kolodkin N. I., Agalakova N. I., Lakatta E. G., Bagrov A. Y., Marinobufagenin, an endogenous α -1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 2001 37 2 462 466 2-s2.0-0035097445 (Pubitemid 32199012)
72. Fedorova O. V., Talan M. I., Agalakova N. I., Lakatta E. G., Bagrov A. Y., Endogenous ligand of α 1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation 2002 105 9 1122 1127 2-s2.0-0037022951 10.1161/hc0902.104710 (Pubitemid 34213289)
73. Anderson D. E., Fedorova O. V., Morrell C. H., Longo D. L., Kashkin V. A., Metzler J. D., Bagrov A. Y., Lakatta E. G., Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2008 294 4 R1248 R1254 2-s2.0-41749087357 10.1152/ajpregu.00782.2007 (Pubitemid 351490645)
74. Manunta P., Stella P., Rivera R., Ciurlino D., Cusi D., Ferrandi M., Hamlyn J. M., Bianchi G., Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999 34 3 450 456 2-s2.0-0032886736 (Pubitemid 29426762)
75. Manunta P., Hamilton B. P., Hamlyn J. M., Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2006 290 3 R553 R559 2-s2.0-33645395096 10.1152/ajpregu.00648.2005
76. Huang B. S., Amin M. S., Leenen F. H. H., The central role of the brain in salt-sensitive hypertension. Current Opinion in Cardiology 2006 21 4 295 304 2-s2.0-33748196482 10.1097/01.hco.0000231398.64362.94 (Pubitemid 44315061)
77. van Huysse J. W., Endogenous brain Na pumps, brain ouabain-like substance and the α 2 isoform in salt-dependent hypertension. Pathophysiology 2007 14 3-4 213 220 2-s2.0-36448931575 10.1016/j.pathophys.2007.09.010 (Pubitemid 350166884)
78. Fedorova O. V., Zhuravin I. A., Agalakova N. I., Yamova L. A., Talan M. I., Lakatta E. G., Bagrov A. Y., Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. Journal of Hypertension 2007 25 9 1834 1844 2-s2.0-34548421083 10.1097/HJH.0b013e328200497a (Pubitemid 47356624)
79. Fedorova O. V., Agalakova N. I., Talan M. I., Lakatta E. G., Bagrov A. Y., Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. Journal of Hypertension 2005 23 8 1515 1523 2-s2.0-23344445972 (Pubitemid 41104823)
80. Kennedy D. J., Vetteth S., Periyasamy S. M., Kanj M., Fedorova L., Khouri S., Kahaleh M. B., Xie Z., Malhotra D., Kolodkin N. I., Lakatta E. G., Fedorova O. V., Bagrov A. Y., Shapiro J. I., Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006 47 3 488 495 2-s2.0-33644988750 10.1161/01.HYP.0000202594. 82271.92 (Pubitemid 43740295)
81. Ferrandi M., Molinari I., Barassi P., Minotti E., Bianchi G., Ferrari P., Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. Journal of Biological Chemistry 2004 279 32 33306 33314 2-s2.0-4043050179 10.1074/jbc.M402187200 (Pubitemid 39062978)
82. 2+ concentrations. Journal of Biological Chemistry 2000 275 36 27838 27844 2-s2.0-0034623226 10.1074/jbc.M002950200
83. Priyadarshi S., Valentine B., Han C., Fedorova O. V., Bagrov A. Y., Liu J., Periyasamy S. M., Kennedy D., Malhotra D., Xie Z., Shapiro J. I., Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney International 2003 63 5 1785 1790 2-s2.0-0242585390 10.1046/j.1523-1755. 2003.00914.x (Pubitemid 36513324)
84. Elkareh J., Kennedy D. J., Yashaswi B., Vetteth S., Shidyak A., Kim E. G. R., Smaili S., Periyasamy S. M., Hariri I. M., Fedorova L., Liu J., Wu L., Kahaleh M. B., Xie Z., Malhotra D., Fedorova O. V., Kashkin V. A., Bagrov A. Y., Shapiro J. I., Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 2007 49 1 215 224 2-s2.0-33847616483 10.1161/01.HYP.0000252409.36927.05 (Pubitemid 46360363)
85. Kennedy D. J., Elkareh J., Shidyak A., Shapiro A. P., Smaili S., Mutgi K., Gupta S., Tian J., Morgan E., Khouri S., Cooper C. J., Periyasamy S. M., Xie Z., Malhotra D., Fedorova O. V., Bagrov A. Y., Shapiro J. I., Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. American Journal of Physiology 2008 294 2 F450 F454 2-s2.0-38849157808 10.1152/ajprenal.00472. 2007 (Pubitemid 351199411)
86. Elkareh J., Periyasamy S. M., Shidyak A., Vetteth S., Schroeder J., Raju V., Hariri I. M., El-Okdi N., Gupta S., Fedorova L., Liu J., Fedorova O. V., Kahaleh M. B., Xie Z., Malhotra D., Watson D. K., Bagrov A. Y., Shapiro J. I., Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. American Journal of Physiology 2009 296 5 F1219 F1226 2-s2.0-66049145239 10.1152/ajprenal.90710.2008
87. Tian J., Shidyak A., Periyasamy S. M., Haller S., Taleb M., El-Okdi N., Elkareh J., Gupta S., Gohara S., Fedorova O. V., Cooper C. J., Xie Z., Malhotra D., Bagrov A. Y., Shapiro J. I., Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension 2009 54 6 1313 1320 2-s2.0-73349127049 10.1161/HYPERTENSIONAHA.109.140038
88. El-Okdi N., Smaili S., Raju V., Shidyak A., Gupta S., Fedorova L., Elkareh J., Periyasamy S., Shapiro A. P., Kahaleh M. B., Malhotra D., Xie Z., Chin K. V., Shapiro J. I., Effects of cardiotonic steroids on dermal collagen synthesis and wound healing. Journal of Applied Physiology 2008 105 1 30 36 2-s2.0-50649112412 10.1152/japplphysiol.00119.2008
89. Fedorova L. V., Raju V., El-Okdi N., Shidyak A., Kennedy D. J., Vetteth S., Giovannucci D. R., Bagrov A. Y., Fedorova O. V., Shapiro J. I., Malhotra D., The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition. American Journal of Physiology 2009 296 4 F922 F934 2-s2.0-65949094589 10.1152/ajprenal.90605.2008
90. Blaustein M. P., Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. American Journal of Physiology, Cell Physiology 1977 232 5 C165 C173 2-s2.0-0017684120 (Pubitemid 8134015)
91. Haddy F. J., Pamnani M. B., Clough D. L., Humoral factors and the sodium-potassium pump in volume expanded hypertension. Life Sciences 1979 24 23 2105 2117 2-s2.0-0018779107
92. de Wardener H. E., Clarkson E. M., Concept of natriuretic hormone. Physiological Reviews 1985 65 3 658 759 2-s2.0-0021840519 (Pubitemid 15033627)
93. Haddy F. J., Overbeck H. W., The role of humoral agents in volume expanded hypertension. Life Sciences 1976 19 7 935 947 2-s2.0-0017188515
94. de Wardener H. E., Clarkson E. M., Concept of natriuretic hormone. Physiological Reviews 1985 65 3 658 759 2-s2.0-0021840519 (Pubitemid 15033627)
95. +-ATPase: modulation of response by physiological manipulation. Clinical and Experimental Pharmacology and Physiology 1998 25 supplement S57 S60 (Pubitemid 28498850)
96. Yates N. A., McDougall J. G., Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep. British Journal of Pharmacology 1993 108 3 627 630 2-s2.0-0027409362 (Pubitemid 23067927)
97. Yates N. A., McDougall J. G., Interaction of exogenous ouabain and chronic mineralocorticoid treatment in the kidney of the conscious sheep. Clinical and Experimental Pharmacology and Physiology 1997 24 1 57 63 2-s2.0-0031040726 (Pubitemid 27101491)
98. de Wardener H. E., MacGregor G. A., Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney International 1980 18 1 1 9 2-s2.0-0019314414 (Pubitemid 10044808)
99. Fedorova O. V., Agalakova N. I., Morrell C. H., Lakatta E. G., Bagrov A. Y., ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 2006 48 6 1160 1168 2-s2.0-33751094574 10.1161/01.HYP.0000248129.20524.d0 (Pubitemid 44772722)
100. Fedorova O. V., Lakatta E. G., Bagrov A. Y., Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of dahl rats. Circulation 2000 102 24 3009 3014 2-s2.0-0034642345
101. Schoner W., Scheiner-Bobis G., Role of endogenous cardiotonic steroids in sodium homeostasis. Nephrology Dialysis Transplantation 2008 23 9 2723 2729 2-s2.0-58149225539 10.1093/ndt/gfn325
102. Yoshika M., Komiyama Y., Konishi M., Akizawa T., Kobayashi T., Date M., Kobatake S., Masuda M., Masaki H., Takahashi H., Novel digitalis-like factor, marinobufotoxin, isolated from cultured Y-1 cells, and its hypertensive effect in rats. Hypertension 2007 49 1 209 214 2-s2.0-33847682886 10.1161/01.HYP. 0000250433.64202.78 (Pubitemid 46360362)
103. Ritz E., Uremic Cardiomyopathy-An Endogenous Digitalis Intoxication? Journal of the American Society of Nephrology 2006 17 6 1493 1497 (Pubitemid 43841395)
104. Bagrov A. Y., Shapiro J. I., Fedorova O. V., Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacological Reviews 2009 61 1 9 38 2-s2.0-63849168850 10.1124/pr.108.000711
105. Haddy F. J., Pamnani M. B., Role of ouabain-like factors and NA-K-ATPase inhibitors in hypertensionsome old and recent findings. Clinical and Experimental Hypertension 1998 20 5-6 499 508 2-s2.0-0031854136 (Pubitemid 28319522)
106. Schoner W., Scheiner-Bobis G., Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. American Journal of Physiology, Cell Physiology 2007 293 2 C509 C536 2-s2.0-34547733409 10.1152/ajpcell.00098.2007 (Pubitemid 47235171)
107. Tian J., Haller S., Periyasamy S., Brewster P., Zhang H., Adlakha S., Fedorova O. V., Xie Z. J., Bagrov A. Y., Shapiro J. I., Cooper C. J., Renal ischemia regulates marinobufagenin release in humans. Hypertension 2010 56 5 914 919 2-s2.0-78149256883 10.1161/HYPERTENSIONAHA.110.155564
108. +-ATPase receptor complex. American Journal of Physiology, Cell Physiology 2008 294 2 C555 C563 2-s2.0-39349094888 10.1152/ajpcell.00475.2007 (Pubitemid 351264404)
109. Liu J., Kesiry R., Periyasamy S. M., Malhotra D., Xie Z., Shapiro J. I., Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney International 2004 66 1 227 241 2-s2.0-3042805201 10.1111/j.1523-1755.2004.00723.x (Pubitemid 38870098)
110. Liu J., Liang M., Liu L., Malhotra D., Xie Z., Shapiro J. I., Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney International 2005 67 5 1844 1854 2-s2.0-17744376590 10.1111/j.1523-1755.2005.00283.x (Pubitemid 40577720)
111. Liu J., Periyasamy S. M., Gunning W., Fedorova O. V., Bagrov A. Y., Malhotra D., Xie Z., Shapiro J. I., Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney International 2002 62 6 2118 2125 2-s2.0-0036434931 10.1046/j.1523-1755.2002.00672.x (Pubitemid 35366166)
112. Oweis S., Wu L., Kiela P. R., Zhao H., Malhotra D., Ghishan F. K., Xie Z., Shapiro J. I., Liu J., Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK 1 cells. American Journal of Physiology 2006 290 5 F997 F1008 2-s2.0-33646575606 10.1152/ajprenal.00322.2005 (Pubitemid 43724898)
113. Periyasamy S. M., Liu J., Tanta F., Kabak B., Wakefield B., Malhotra D., Kennedy D. J., Nadoor A., Fedorova O. V., Gunning W., Xie Z., Bagrov A. Y., Shapiro J. I., Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney International 2005 67 5 1868 1877 2-s2.0-20244387156 10.1111/j.1523-1755.2005.00285.x (Pubitemid 40577722)
114. Liu J., Jiang.Liu@utoledo.edu Yan Y., Liu L., Xie Z., Malhotra D., Joe B., Shapiro J. I., Impairment of Na/K-ATPase signaling in renal proximal tubule contributes to Dahl salt-sensitive hypertension. Journal of Biological Chemistry 2011 286 26 22806 22813 10.1074/jbc.M111.246249
115. Dahl L. K., Heine M., Tassinari L., Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 1962 194 4827 480 482 2-s2.0-1842597403 10.1038/194480b0
116. Dahl L. K., Knudsen K. D., Iwai J., Humoral transmission of hypertension: evidence from parabiosis. Circulation Research 1969 24 5, supplement 21 33 2-s2.0-0014511397
117. Rapp J. P., Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 1982 4 6 753 763 (Pubitemid 13176940)
118. Rapp J. P., Dene H., Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 1985 7 3 340 349 2-s2.0-0021858418 (Pubitemid 15021172)
119. Mokry M., Cuppen E., The Atp1a1 gene from inbred Dahl salt sensitive rats does not contain the A1079T missense transversion. Hypertension 2008 51 4 922 927 2-s2.0-42049097049 10.1161/HYPERTENSIONAHA.107.108415 (Pubitemid 351654705)
120. Yamori Y., Ganten D., de Jong W., The development of Spontaneously Hypertensive Rat (SHR) and of various spontaneous rat models, and their implications. Experimental and Genetic Models of Hypertension 1984 4 New York, NY, USA Elsevier 224 239 Handbook of Hypertension
121. Pace-Asciak C. R., Carrara M. C., Reduction in dietary vitamin E prevents onset of hypertension in developing spontaneously hypertensive rats. Experientia 1979 35 12 1561 1562 2-s2.0-0018638491 (Pubitemid 10097591)
122. Young J. B., Mullen D., Landsberg L., Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism 1978 27 12 1711 1714 2-s2.0-0018241902 (Pubitemid 9085439)
123. Adams N., Blizard D. A., Genetic and maternal influences in rat models of spontaneous and salt-induced hypertension. Developmental Psychobiology 1991 24 7 507 519 2-s2.0-0026249167
124. Arendshorst W. J., Beierwaltes W. H., Renal tubular reabsorption in spontaneously hypertensive rats. The American Journal of Physiology 1979 237 1 F38 47 2-s2.0-0018497074 (Pubitemid 10234599)
125. Beierwaltes W. H., Arendshorst W. J., Renal function of conscious spontaneously hypertensive rats. Circulation Research 1978 42 5 721 726 2-s2.0-0017842495 (Pubitemid 8353155)
126. Arendshorst W. J., Autoregulation of renal blood flow in spontaneously hypertensive rats. Circulation Research 1979 44 3 344 349 2-s2.0-0018383712 (Pubitemid 9132961)
127. Crajoinas R. O., Lessa L. M. A., Carraro-Lacroix L. R., Davel A. P. C., Pacheco B. P. M., Rossoni L. V., Malnic G., Girardi A. C. C., Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR. American Journal of Physiology 2010 299 4 F872 F881 2-s2.0-77957973732 10.1152/ajprenal.00654.2009
128. + exchange activity and NHE-3 expression in renal tubules from the spontaneously hypertensive rat. Kidney International 2002 62 1 157 165 2-s2.0-0036311150 10.1046/j.1523-1755.2002.00406.x (Pubitemid 34754058)
129. Garg L. C., Narang N., McArdle S., Na-K-ATPase in nephron segments of rats developing spontaneous hypertension. The American Journal of Physiology 1985 249 6 F863 869 2-s2.0-0022322171 (Pubitemid 16171221)
130. +-ATPase in weanling and adult spontaneously hypertensive rats. Proceedings of the Society for Experimental Biology and Medicine 1984 177 2 240 246 2-s2.0-0021689720 (Pubitemid 15203527)
131. Garg L. C., Narang N., Differences in renal tubular Na-K-adenosine triphosphatase in spontaneously hypertensive and normotensive rats. Journal of Cardiovascular Pharmacology 1986 8 1 186 189 2-s2.0-0022587462 (Pubitemid 16149410)
132. Garg L. C., Narang N., Effects of hydrochlorothiazide on Na-K-ATPase activity along the rat nephron. Kidney International 1987 31 4 918 922 2-s2.0-0023124083 (Pubitemid 17044896)
133. Morduchowicz G. A., Sheikh-Hamad D., Jo O. D., Nord E. P., Lee D. B. N., Yanagawa N., Increased Na+/H+ antiport activity in the renal brush border membrane of SHR. Kidney International 1989 36 4 576 581 2-s2.0-0024467707 (Pubitemid 19239548)
134. Hayward A. L., Hinojos C. A., Nurowska B., Hewetson A., Sabatini S., Oefner P. J., Doris P. A., Altered sodium pump alpha and gamma subunit gene expression in nephron segments from hypertensive rats. Journal of Hypertension 1999 17 8 1081 1087 2-s2.0-0032772807 10.1097/00004872-199917080-00006 (Pubitemid 29389554)
135. Kourie J. I., Interaction of reactive oxygen species with ion transport mechanisms. American Journal of Physiology, Cell Physiology 1998 275 1 C1 C24 2-s2.0-0031857290 (Pubitemid 28381298)
136. Chabrashvili T., Tojo A., Onozato M. L., Kitiyakara C., Quinn M. T., Fujita T., Welch W. J., Wilcox C. S., Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002 39 2 269 274 2-s2.0-0036175986 10.1161/hy0202.103264 (Pubitemid 34165227)
137. + exchanger 3. Hypertension 2009 54 6 1291 1297 2-s2.0-73349089360 10.1161/HYPERTENSIONAHA.109. 134783
138. + exchanger 3 is impaired during oxidative stress. American Journal of Physiology, Renal Physiology 2011 301 2 F364 F370 10.1152/ajprenal.00121.2011
139. Dada L. A., Novoa E., Lecuona E., Sun H., Sznajder J. I., Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells. Journal of Cell Science 2007 120 13 2214 2222 2-s2.0-34447522003 10.1242/jcs.003038 (Pubitemid 47074125)
140. +-ATPase in hydrogen peroxide-induced hypertrophy in cardiac myocytes. Free Radical Biology and Medicine 2006 41 10 1548 1556 2-s2.0-33749528322 10.1016/j.freeradbiomed.2006.08.018 (Pubitemid 44528254)
141. +- ATPase to hypertrophy and its marker genes in cardiac myocytes. Journal of Biological Chemistry 1999 274 27 19323 19328 2-s2.0-0033516649 10.1074/jbc.274.27.19323 (Pubitemid 29314137)
142. Tian J., Liu J., Garlid K. D., Shapiro J. I., Xie Z., Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial KATP channels. Molecular and Cellular Biochemistry 2003 242 1-2 181 187 2-s2.0-0037284344 10.1023/A:1021114501561 (Pubitemid 36240544)
143. Miyakawa-Naito A., Uhlén P., Lal M., Aizman O., Mikoshiba K., Brismar H., Zelenin S., Aperia A., Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. Journal of Biological Chemistry 2003 278 50 50355 50361 2-s2.0-0346118913 10.1074/jbc.M305378200 (Pubitemid 37548878)
144. Kajikawa M., Fujimoto S., Tsuura Y., Mukai E., Takeda T., Hamamoto Y., Takehiro M., Fujita J., Yamada Y., Seino Y., Ouabain suppresses glucose-induced mitochondrial ATP production and insulin release by generating reactive oxygen species in pancreatic islets. Diabetes 2002 51 8 2522 2529 2-s2.0-0036326796 (Pubitemid 34827402)
145. Huang Y. T., Chueh S. C., Teng C. M., Guh J. H., Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. Biochemical Pharmacology 2004 67 4 727 733 2-s2.0-1642534349 10.1016/j.bcp.2003.10.013 (Pubitemid 38125256)
146. Boldyrev A., Bulygina E., Yuneva M., Schoner W., Na/K-ATPase regulates intracellular ROS level in cerebellum neurons. Annals of the New York Academy of Sciences 2003 986 519 521 2-s2.0-0038751937 (Pubitemid 36584158)
147. Kennedy D. J., Vetteth S., Xie M., Periyasamy S. M., Xie Z., Han C., Basrur V., Mutgi K., Fedorov V., Malhotra D., Shapiro J. I., Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation. American Journal of Physiology, Heart and Circulatory Physiology 2006 291 6 H3003 H3011 2-s2.0-33845420039 10.1152/ajpheart.00603.2006 (Pubitemid 44904102)
148. Glynn I. M., Transport adenosinetriphosphatase in electric organ. The relation between ion transport and oxidative phosphorylation. The Journal of Physiology 1963 169 2 452 465
149. +-pump activity and delays fatigue during prolonged exercise in humans. Journal of Physiology 2006 576 1 279 288 2-s2.0-33748905385 10.1113/jphysiol.2006.115352 (Pubitemid 44426236)
150. Boldyrev A., boldyrev@inevro.msk.su Kurella E., Mechanism of oxidative damage of dog kidney Na/K-ATPase. Biochemical and Biophysical Research Communications 1996 222 2 483 487 10.1006/bbrc.1996.0770 (Pubitemid 26335042)
151. Dobrota D., Matejovicova M., Kurella E. G., Boldyrev A. A., Na/K-ATPase under oxidative stress: molecular mechanisms of injury. Cellular and Molecular Neurobiology 1999 19 1 141 149 2-s2.0-0033041134 (Pubitemid 29102102)
152. Kurella E. G., Tyulina O. V., Boldyrev A. A., Oxidative resistance of Na/K-ATPase. Cellular and Molecular Neurobiology 1999 19 1 133 140 2-s2.0-0033035317 (Pubitemid 29102101)
153. Petrushanko I., Bogdanov N., Bulygina E., Grenacher B., Leinsoo T., Boldyrev A., Gassmann M., Bogdanova A., Na-K-ATPase in rat cerebellar granule cells is redox sensitive. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2006 290 4 R916 R925 2-s2.0-33646470865 10.1152/ajpregu.00038.2005
154. Bogdanova A., Boldyrev A., Gassmann M., Oxygen- and redox-induced regulaton of the Na/K ATPase. Current Enzyme Inhibition 2006 2 1 37 59 2-s2.0-33646479107 10.2174/157340806775473490 (Pubitemid 44082962)
155. Ellis D. Z., Rabe J., Sweadner K. J., Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience 2003 23 1 43 51 2-s2.0-0037221596 (Pubitemid 36050403)
156. +-ATPase. American Journal of Physiology, Heart and Circulatory Physiology 1987 252 2 H252 H257 2-s2.0-17144457672
157. Xie Z., Wang Y., Askari A., Huang W. H., Klaunig J. E., Askari A., Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. Journal of Molecular and Cellular Cardiology 1990 22 8 911 920 2-s2.0-0025127024 10.1016/0022-2828(90)90122-I (Pubitemid 20281903)
158. +)-ATPase: inactivation and degradation induced by oxygen radicals. International Journal of Biochemistry 1992 24 4 621 626 2-s2.0-0026578329
159. +-ATPase isoforms to oxidants. Biochimica et Biophysica Acta, Biomembranes 1994 1190 1 108 114 2-s2.0-0028118572 10.1016/0005-2736(94)90039-6 (Pubitemid 24066265)
160. +-ATPase to intracellular proteinases. Biochimica et Biophysica Acta, Biomembranes 1994 1192 1 125 131 10.1016/0005-2736(94)90152-X (Pubitemid 24171551)
161. +-ATPase expressed in baculovirus-infected insect cells. Biochemical and Biophysical Research Communications 1995 207 1 155 159 10.1006/bbrc.1995.1166
162. Mense M., Stark G., Apell H. J., Effects of free radicals on partial reactions of the Na,K-ATPase. Journal of Membrane Biology 1997 156 1 63 71 2-s2.0-0030896850 10.1007/s002329900188 (Pubitemid 27150013)
163. +-ATPase through proteasomal and endo- /lysosomal proteolytic pathways. FASEB Journal 1999 13 13 1751 1761 2-s2.0-0038271589 (Pubitemid 29473337)
164. + pump via PKC-dependent activation of NADPH oxidase. American Journal of Physiology, Cell Physiology 2009 296 4 C693 C700 2-s2.0-65649149115 10.1152/ajpcell.00648.2008
165. + pump regulation. Circulation Research 2009 105 2 185 193 2-s2.0-68049096878 10.1161/CIRCRESAHA.109.199547
166. + pump mediated by glutathionylation of its β 1 subunit. Journal of Biological Chemistry 2011 286 21 18562 18572 10.1074/jbc.M110.184101
167. Reifenberger M. S., Arnett K. L., Gatto C., Milanick M. A., The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity. American Journal of Physiology 2008 295 4 F1191 F1198 2-s2.0-57049166025 10.1152/ajprenal.90296.2008
168. +-ATPase activity by angiotensin II in the rat proximal tubule. Nitric Oxide 2002 7 1 30 35 2-s2.0-0036040161 10.1016/S1089-8603(02)00003-4 (Pubitemid 35007257)
169. Zhang A. Y., Yi F., Zhang G., Gulbins E., Li P. L., Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006 47 1 74 80 2-s2.0-31744443116 10.1161/10.1161/01.HYP. 0000196727.53300.62 (Pubitemid 43177818)
170. Zuo L., Ushio-Fukai M., mfukai@emory.edu Ikeda S., Hilenski L., Patrushev N., Alexander R. W., Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 9 1824 1830 10.1161/01.ATV.0000175295.09607.18 (Pubitemid 41243449)
171. Touyz R. M., Lipid rafts take center stage in endothelial cell redox signaling by death receptors. Hypertension 2006 47 1 16 18 2-s2.0-31744449420 10.1161/01.HYP.0000196730.13216.f3 (Pubitemid 43177808)
172. Han W., Li H., Villar V. A. M., Pascua A. M., Dajani M. I., Wang X., Natarajan A., Quinn M. T., Felder R. A., Jose P. A., Yu P., Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 2008 51 2 481 487 2-s2.0-38549175644 10.1161/HYPERTENSIONAHA.107. 103275 (Pubitemid 351156436)
173. Seshiah P. N., Weber D. S., Rocic P., Valppu L., Taniyama Y., Griendling K. K., Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circulation Research 2002 91 5 406 413 2-s2.0-0037032024 10.1161/01.RES.0000033523.08033.16 (Pubitemid 35034208)
174. Touyz R. M., touyzr@ircm.qc.ca Yao G., Schiffrin E. L., c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 6 981 987 10.1161/01.ATV.0000069236. 27911.68 (Pubitemid 36717143)
175. Paravicini T. M., Touyz R. M., Redox signaling in hypertension. Cardiovascular Research 2006 71 2 247 258 2-s2.0-33745193908 10.1016/j.cardiores.2006.05.001
176. Wilcox C. S., Gutterman D., Focus on oxidative stress in the cardiovascular and renal systems. American Journal of Physiology, Heart and Circulatory Physiology 2005 288 1 H3 H6 2-s2.0-11144271387 10.1152/ajpheart. 00854.2004 (Pubitemid 40023820)
177. Touyz R. M., Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004 44 3 248 252 2-s2.0-4444329422 10.1161/01.HYP.0000138070.47616.9d (Pubitemid 39167216)
178. Lacy F., Kailasam M. T., O'Connor D. T., Schmid-Schönbein G. W., Parmer R. J., Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000 36 5 878 884 2-s2.0-0033695425
179. Lacy F., O'Connor D. T., Schmid-Schönbein G. W., Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. Journal of Hypertension 1998 16 3 291 303 2-s2.0-0031888499 10.1097/00004872-199816030-00006 (Pubitemid 28101757)
180. Vaziri N. D., ndvaziri@uci.edu Rodríguez-Iturbe B., Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nature Clinical Practice Nephrology 2006 2 10 582 593 10.1038/ncpneph0283 (Pubitemid 44465680)
181. Wilcox C. S., Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? American Journal of Physiology, Regulatory, Integrative and Comparative Physiology 2005 289 4 R913 R935 (Pubitemid 41397037)
182. Welch W. J., welchw@georgetown.edu Intrarenal oxygen and hypertension. Clinical and Experimental Pharmacology and Physiology 2006 33 10 1002 1005 10.1111/j.1440-1681.2006.04478.x (Pubitemid 44427325)
183. Kitiyakara C., Chabrashvili T., Chen Y., Blau J., Karber A., Aslam S., Welch W. J., Wilcox C. S., Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. Journal of the American Society of Nephrology 2003 14 11 2775 2782 2-s2.0-0142182739 10.1097/01.ASN.0000092145. 90389.65 (Pubitemid 37305640)
184. Schreck C., O'Connor P. M., poconnor@mcw.edu NAD(P)H oxidase and renal epithelial ion transport. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2011 300 5 R1023 R1029 10.1152/ajpregu.00618.2010
185. Han H. J., Yun J. L., Su H. P., Jang H. L., Taub M., High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. American Journal of Physiology 2005 288 5 F988 F996 2-s2.0-17644397486 10.1152/ajprenal.00327.2004 (Pubitemid 40569765)
186. + exchange in the thick ascending limb. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2006 290 1 R79 R83 10.1152/ajpregu. 00447.2005
187. Cowley A. W., Mori T., Mattson D., Zou A. P., Role of renal NO production in the regulation of medullary blood flow. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2003 284 6 R1355 R1369 2-s2.0-0038811878 (Pubitemid 36621413)
188. 2 leads to hypertension. Hypertension 2003 42 1 25 30 2-s2.0-0038480710 10.1161/01.HYP.0000074903.96928.91 (Pubitemid 36842232)
189. 2 on salt-induced hypertension and renal injury. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2005 289 6 R1573 R1579 10.1152/ajpregu.00525.2005 (Pubitemid 41643199)
190. Taylor N. E., Glocka P., Liang M., Cowley A. W., NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 2006 47 4 692 698 2-s2.0-33645832749 10.1161/01.HYP.0000203161.02046.8d (Pubitemid 43740240)
191. Cao C., Edwards A., Sendeski M., Lee-Kwon W., Cui L., Cai C. Y., Patzak A., Pallone T. L., Intrinsic nitric oxide and superoxide production regulates descending vasa recta contraction. American Journal of Physiology 2010 299 5 F1056 F1064 2-s2.0-78349299753 10.1152/ajprenal.00070.2010
192. Edwards A., aurelie.edwards@tufts.edu Cao C., Pallone T. L., Cellular mechanisms underlying nitric oxide-induced vasodilation of descending vasa recta. American Journal of Physiology, Renal Physiology 2011 300 2 F441 F456 10.1152/ajprenal.00499.2010
193. Yang Z., Asico L. D., Yu P., Wang Z., Jones J. E., Escano C. S., Wang X., Quinn M. T., Sibley D. R., Romero G. G., Felder R. A., Jose P. A., D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2006 290 1 R96 R104 2-s2.0-33644833318 10.1152/ajpregu.00434.2005
194. Kopkan L., Majid D. S., Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension. 2005 46 4 1026 1031 2-s2.0-33644654045
195. Kopkan L., Hess A., Husková Z., Červenka L., Navar L. G., Majid D. S. A., High-salt intake enhances superoxide activity in enos knockout mice leading to the development of salt sensitivity. American Journal of Physiology 2010 299 3 F656 F663 2-s2.0-77956480688 10.1152/ajprenal.00047.2010
196. Zhang R., Hording P., Garvin J. L., Juncos R., Peterson E., Juncos L. A., Liu R., Isoforms and functions of NAD(P)H oxidase at the macula densa. Hypertension 2009 53 3 556 563 2-s2.0-61749089305 10.1161/HYPERTENSIONAHA.108. 124594
197. Ortiz P. A., Garvin J. L., Superoxide stimulates NaCl absorption by the thick ascending limb. American Journal of Physiology 2002 283 5 F957 F962 2-s2.0-0036839125 (Pubitemid 35192462)
198. Mori T., Cowley A. W., Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003 42 4 588 593 2-s2.0-0141893554 10.1161/01.HYP. 0000091821.39824.09 (Pubitemid 37237358)
199. Johns E. J., O'Shaughnessy B., O'Neill S., Lane B., Healy V., Impact of elevated dietary sodium intake on NAD(P)H oxidase and SOD in the cortex and medulla of the rat kidney. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2010 299 1 R234 R240 2-s2.0-77954413327 10.1152/ajpregu.00541.2009
200. + transport by a cGMP-mediated mechanism in the kidney proximal tubule. American Journal of Physiology, Renal Physiology 1997 272 2 F242 F248
201. Li H., Han W., Van Villar A. M., Keever L. B., Lu Q., Hopfer U., Quinn M. T., Felder R. A., Jose P. A., Yu P., D1-like receptors regulate nadph oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension 2009 53 6 1054 1061 2-s2.0-67049095506 10.1161/HYPERTENSIONAHA.108.120642
202. Banday A. A., Lokhandwala M. F., Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Hypertension 2008 52 6 1099 1105 2-s2.0-57449088384 10.1161/HYPERTENSIONAHA.108.117911
203. + antiporter activity in renal cortical apical membrane vesicles. American Journal of Physiology-Renal Fluid and Electrolyte Physiology 1991 260 1 F130 F137 2-s2.0-0026078684
204. + transporter subcellular distribution, abundance, and phosphorylation status. American Journal of Physiology 2008 295 4 F1003 F1016 2-s2.0-57049179612 10.1152/ajprenal.90235.2008
205. Liu J., Jiang.Liu@utoledo.edu Yan Y., Liu L., Xie Z., Malhotra D., Joe B., Shapiro J. I., Impairment of Na/K-ATPase signaling in renal proximal tubule contributes to Dahl salt-sensitive hypertension. Journal of Biological Chemistry 2011 286 26 22806 22813 10.1074/jbc.M111.246249
206. Fisher K. A., Lee S. H., Walker J., Dileto-Fang C., Ginsberg L., Stapleton S. R., Regulation of proximal tubule sodium/hydrogen antiporter with chronic volume contraction. American Journal of Physiology 2001 280 5 F922 F926 2-s2.0-0035036894
207. +-ATPase in opossum kidney cells. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2007 293 4 R1764 R1770 2-s2.0-35148890324 10.1152/ajpregu.00425.2007 (Pubitemid 47535796)
208. McDonough A. A., Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2010 298 4 R851 R861 2-s2.0-77949801479 10.1152/ajpregu.00002.2010
209. Yang L. E., Leong P. K. K., McDonough A. A., Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance. American Journal of Physiology 2007 293 4 F1197 F1208 2-s2.0-35348817994 10.1152/ajprenal.00040.2007 (Pubitemid 47583953)
210. Pallone T. L., Control of renal Na+ excretion by heme oxygenase. Hypertension 2007 49 1 23 24 2-s2.0-33847622901 10.1161/01.HYP.0000250089.99513. f6 (Pubitemid 46360335)
211. Zou A. P., Billington H., Su N., Cowley A. W., Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 2000 35 1 342 347 2-s2.0-0033979878 (Pubitemid 30054197)
212. Rodriguez F., Zhang F., Dinocca S., Nasjletti A., Nitric oxide synthesis influences the renal vascular response to heme oxygenase inhibition. American Journal of Physiology 2003 284 6 F1255 F1262 2-s2.0-0038284838 (Pubitemid 36578453)
213. Arregui B., López B., Salom M. G., Valero F., Navarro C., Fenoy F. J., Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin. Kidney International 2004 65 2 564 574 2-s2.0-1642520796 10.1111/j.1523-1755.2004.00409.x (Pubitemid 38130650)
214. Johnson R. A., Lavesa M., Askari B., Abraham N. G., Nasjletti A., A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1995 25 2 166 169 2-s2.0-0028814999
215. Hirakawa H., Hayashida Y., Autonomic cardiovascular responses to heme oxygenase inhibition in conscious rats. Hypertension 2006 48 6 1124 1129 2-s2.0-33751084080 10.1161/01.HYP.0000245678.56354.21 (Pubitemid 44772717)
216. Johnson R. A., Lavesa M., Deseyn K., Scholer M. J., Nasjletti A., Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. American Journal of Physiology 1996 271 3 H1132 H1138 2-s2.0-0029794199
217. Levere R. D., Martasek P., Escalante B., Schwartzman M. L., Abraham N. G., Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. Journal of Clinical Investigation 1990 86 1 213 219 2-s2.0-0025332748 (Pubitemid 20226994)
218. Sacerdoti D., Escalante B., Abraham N. G., McGiff J. C., Levere R. D., Schwartzman M. L., Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989 243 4889 388 390 2-s2.0-0024587145 (Pubitemid 19047515)
219. Sabaawy H. E., Zhang F., Nguyen X., ElHosseiny A., Nasjletti A., Schwartzman M., Dennery P., Kappas A., Abraham N. G., Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001 38 2 210 215 2-s2.0-0035569053 (Pubitemid 34224746)
220. Wang R., Shamloul R., Wang X., Meng Q., Wu L., Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006 48 4 685 692 2-s2.0-33750577971 10.1161/01.HYP.0000239673. 80332.2f (Pubitemid 44843873)
221. Johnson F. K., Durante W., Peyton K. J., Johnson R. A., Heme oxygenase inhibitor restores arteriolar nitric oxide function in dahl rats. Hypertension 2003 41 1 149 155 2-s2.0-0037217407 10.1161/01.HYP.0000046923.52222.58 (Pubitemid 36056807)
222. Teran F. J., Johnson R. A., Stevenson B. K., Peyton K. J., Jackson K. E., Appleton S. D., Durante W., Johnson F. K., Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2005 288 3 R615 R622 2-s2.0-13844269013 10.1152/ajpregu.00123.2004 (Pubitemid 40250570)
223. Johnson R. A., Teran F. J., Durante W., Peyton K. J., Johnson F. K., Enhanced heme oxygenase-mediated coronary vasodilation in Dahl salt-sensitive hypertension. American Journal of Hypertension 2004 17 1 25 30 2-s2.0-0346689986 10.1016/j.amjhyper.2003.08.009 (Pubitemid 38064755)
224. Katavetin P., Inagi R., Miyata T., Shao J., Sassa R., Adler S., Eto N., Kato H., Fujita T., Nangaku M., mnangaku-tky@umin.ac.jp Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochemical and Biophysical Research Communications 2007 359 4 928 934 10.1016/j.bbrc.2007.05. 207 (Pubitemid 46946906)
225. Münzel T., Gori T., Bruno R. M., Taddei S., Is oxidative stress a therapeutic target in cardiovascular disease? European Heart Journal 2010 31 22 2741 2748 2-s2.0-78649357316 10.1093/eurheartj/ehq396
226. Appel L. J., Moore T. J., Obarzanek E., Vollmer W. M., Svetkey L. P., Sacks F. M., Bray G. A., Vogt T. M., Cutler J. A., Windhauser M. M., Lin P. -H., Karanja N., Simons-Morton D., McCullough M., Swain J., Steele P., Evans M. A., Miller III E. R., Harsha D. W., A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 1997 336 16 1117 1124 10.1056/NEJM199704173361601 (Pubitemid 27374693)
227. Miller E. R. III, Appel L. J., Risby T. H., Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation 1998 98 22 2390 2395 2-s2.0-0032401668 (Pubitemid 28549782)
228. John J. H., Ziebland S., Yudkin P., Roe L. S., Neil H. A. W., Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002 359 9322 1969 1974 2-s2.0-0037042466 10.1016/S0140-6736(02)98858-6 (Pubitemid 34663710)
229. Collins R., Armitage J., Parish S., Sleight P., Peto R., MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360 9326 23 33 2-s2.0-0037031094 10.1016/S0140-6736(02)09328-5 (Pubitemid 34756488)
230. Galley H. F., Thornton J., Howdle P. D., Walker B. E., Webster N. R., Combination oral antioxidant supplementation reduces blood pressure. Clinical Science 1997 92 4 361 365 2-s2.0-0030895186 (Pubitemid 27163093)
231. Ceriello A., Giugliano D., Quatraro A., Lefebvre P. J., Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clinical Science 1991 81 6 739 742 2-s2.0-0026009602
232. Ceriello A., Motz E., Giugliano D., Hypertension and ascorbic acid. Lancet 2000 355 9211 1272 1273
233. Huang H.-Y., Caballero B., Chang S., Alberg A. J., Semba R. D., Schneyer C. R., Wilson R. F., Cheng T. Y., Vassy J., Prokopowicz G., Barnes G. J., Bass E. B., The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Annals of Internal Medicine 2006 145 5 372 385 2-s2.0-33749050338 (Pubitemid 46768595)
234. Garvin J. L., Ortiz P. A., The role of reactive oxygen species in the regulation of tubular function. Acta Physiologica Scandinavica 2003 179 3 225 232 10.1046/j.0001-6772.2003.01203.x (Pubitemid 37474083)